Heidelberg Pharma granted orphan drug designation by FDA for its proprietary ATAC candidate HDP-101 marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
EQS-News: Heidelberg Pharma granted orphan drug designation by FDA for its proprietary ATAC candidate HDP-101 finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.
EQS-News: Heidelberg Pharma AG / Key word: Annual Results
Heidelberg Pharma announces financial figures and reports on successful business performance in 2023
25.03.2024.